HIV Risk Reduction in Subutex Injectors in Tbilisi

NCT01131273 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

DRUG: methadone
DRUG: buprenorphine-naloxone (Suboxone) for 12 weeks

Sponsor

University of Pennsylvania

Collaborators

[object Object]